Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? The Motley Fool 3d
CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks 5d
Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? The Motley Fool 3d CRISPR Therapeutics Biology Biotechnology
CRISPR activation library uncovers gene driving lymphoma growth and resistance News-Medical.Net 2d Cancer Cancer Treatment Blood Cancer
Patient-derived tumour organoid biobank maps cancer gene dependencies Drug Target Review 11:36 Wed, 02 Sep Cancer Nature Organoids
CRISPR’s ability to knock down RNA may be artificially inflated The Scientist 05:14 Thu, 10 Sep Biology Biotechnology Nature All sources
Weekly reads: Longeveron MSC trial disappoints, CRISPR ancestor Vipr, distinct human brain progenitors, FDA staffing woes The Niche (Weblog) 13h FDA CRISPR/Gene Editing Pharma
Could a daily glass of orange juice support heart health? Study finds citrus compounds influence genes linked to blood vessel function News-Medical.Net 4d Genetics Global Health Science
Antengene publishes preclinical research paper on CD73 small Molecule inhibitor atg-037 combined with selinexor in cancer gene therapy PR Newswire (Press Release) 7d China Politics Biotechnology Biotech
